Home

TRASYLOL® INVESTIGATION

Trayslol®
Free Trasylol® Claim Evaluation
Please enter all required information to complete your Trasylol® claim evaluation. Someone will contact you shortly.

Name*
Email Address*
Phone Number*
Has death occured?  
Check if yes.

Comments


FREE CLAIM EVALUATION
CONTACT US AT (866) 495-5189

ATTORNEY ADVERTISING.
PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.

The law firm of Milberg LLP is pursuing litigation against Bayer Pharmaceuticals relating to the withdrawal from the market of the drug Trasylol® in November 2007.

Trasylol® (also known as aprotinin) was approved by the FDA in 1993 to control bleeding and limit the need for transfusions in patients undergoing coronary artery bypass grafting surgery (CABG). Several studies have linked this drug to an increased risk of death, cardiac events and renal failure resulting in the need for dialysis. In particular, two new studies published on February 28, 2008 in the New England Journal of Medicine confirmed an increased risk of death in patients given the anti-bleeding drug Trasylol®.

The release of these two new Trasylol studies follows a 60 Minutes interview with medical researcher Dr. Dennis Mangano, which aired on February 17, 2008. Dr. Mangano conducted a ground breaking study which included 5,065 patients in 17 countries. The study, published in the New England Journal of Medicine in January 2006, revealed that patients treated with Trasylol® have twice the rate of kidney failure and an increased risk of heart attacks, heart failures, strokes and encephalopathy.

In the 60 Minutes report, Mangano stated that the FDA should have pulled Trasylol® from the market in January 2006, after the release of his study; instead the drug remained on the market until November 2007. Between that time, approximately 431,000 patients received the drug. According to Mangano, 22,000 lives (1,000 per month) could have been saved if the drug were taken off the market in January 2006.

If you or a loved one believe that Trasylol® have been administered during heart surgery, please contact us at 1-866-495-5189.

You may not be aware that you were given the drug since it is given during surgery. However, this information can be determined from a review of your medical records which we will obtain on your behalf.

You may be legally entitled to recover medical expenses, lost earnings, as well as compensation for physical pain and suffering, mental anguish and physical impairment. For persons who have died, their surviving spouse or other family members often can bring a wrongful death action.

Milberg LLP
One Pennsylvania Plaza, 49th Fl.
New York, NY, 10119-0165
Phone number: (866) 495-5189
Email: ContactUs@milberg.com
Website: http://www.milberg.com

ATTORNEY ADVERTISING.
PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.


ATTORNEY ADVERTISING.  PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.